Description:
 
Background
This technology uses mass spectrometry as a diagnostic for early detection of cancer by analyzing breath aerosol from inhalation face masks.
 
Technology Overview
In this invention, the subject wears a routine inhalation face mask for a short time, which collects breath aerosol. The breath-exposed part of the mask is cut out, and detected by mass spectrometry after derivatization to enhance sensitivity.
 
Benefits
- Provides clinical diagnostics with maximum convenience 
- Provides clinical diagnostics with minimal invasiveness 
 
Applications
- Clinical diagnostics
 
Opportunity
- License
- Partnering
- Research collaboration
Patent Information:
For Information, Contact:
Mark Saulich
Associate Director of Commercialization
Northeastern University
m.saulich@northeastern.edu
Inventors:
Pushkar Kulkarni
Poguang Wang
Roger Giese
Keywords:
Cancer
Chemistry
Detection
Devices
Diagnostic Software
Diagnostics
Health
Healthcare Innovation
Medical/Health